RiboX Therapeutics Announces First Patient Dosed in Phase I/IIa Clinical Trial of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation
China Telecom and Partners Innovate Together! 5G UAV Medical Delivery Network Wins Global Mobile Award
AIM Vaccine's Iteratively Upgraded Diploid Rabies Vaccine Approved for Clinical Trials, Showing Significantly Higher Efficacy than Marketed Diploid Rabies Vaccines
U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®
Appian Unveils Latest Platform Release for Faster, More Powerful Data Fabric and AI Experience
HKA WELCOMES FORENSIC ACCOUNTING EXPERT JACQUELINE WOODS TO HKA IN AUSTRALIA
Aeroband Hits the Right Note at SXSW: The Best Smart Musical Instrument Brand Inspiring the Future of Music
Global Times: Up Close: President Xi joins national political advisors in education discussion
